MAP2K5 and ovarian carcinoma: To explore the in vivo growth properties of ovarian cancer cells in which the WNK1–MEKK2–MEK5–ERK5 route has been interrupted, we deleted MEK5 of OVCAR8 cells using CRISPR/Cas9.